Stay updated on Inhaled QBW276 in CF: Safety, PK, PD Clinical Trial
Sign up to get notified when there's something new on the Inhaled QBW276 in CF: Safety, PK, PD Clinical Trial page.

Latest updates to the Inhaled QBW276 in CF: Safety, PK, PD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays the clinical trial record for inhaled QBW276 in people with cystic fibrosis, including eligibility, study design, locations, outcome measures, and posted documents. The record notes that the study was completed and terminated after Cohort 2.SummaryDifference47%

- Check15 days agoChange DetectedThe site footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error page, indicating access is blocked. This replaces the previous study-record content with a minimal layout and header/footer.SummaryDifference18%

Stay in the know with updates to Inhaled QBW276 in CF: Safety, PK, PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled QBW276 in CF: Safety, PK, PD Clinical Trial page.